Researchers, providers need to address cancer health care disparities in LGBTQ community
the ONA take:
An article by researchers from the Moffitt Cancer Center describes disparities in cancer care for the Lesbian, Gay, Bisexual, Transgender/Transsexual, Queer/Questioning (LGBTQ) community. Adults in the LGBTQ community tend to be lower economic status and seek health care less often.
In addition, knowledge about cancer in this community is significantly less than what is known about the heterosexual community.
In analyzing the current LGBTQ literature on prevention, early detection, diagnosis, treatment, and survivorship in this community, the researchers found this minority population to be medically underserved.
Incidence and death rates of some cancers are higher for subgroups of LGBTQ patients, such as anal cancer in gay men and cervical cancer in lesbian and bisexual women. Furthermore, data does not reflect the cultural differences in each of these population groups.
The Moffitt researchers recommend all surveys and registries collect information on gender identity and sexual orientation so more comprehensive data is available on the impact of cancer in this community.
The cancer-related needs of the LGBTQ community are a crucial area to be addressed by the health care providers and the research community, explained a senior member of the Health Outcomes and Behavior Program at Moffitt.
Adults in the LGBTQ community tend to be lower economic status and seek health care less often.
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- G-CSF May Help Preserve Fertility in Male Patients With Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Patients With HER2-enriched Subtype Benefit Most from Dual HER2 Blockade
- Scalp Cooling Reduces Risk of Chemotherapy-Induced Alopecia
- CRISPR Illustrates Progression of Normal Blood Cells to Leukemia, Precursor Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|